Hekakare Pharmaceuticals Private Limited
About Hekakare Pharmaceuticals Private Limited
Data last updated:
Hekakare Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 24 February 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2023PTC410575.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹50,000. It is led by directors Arvind Kumar Srivastava and Hridesh Kumar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ugf29/500/20/A/2, Gali No 2, New Delhi, Delhi, India – 110032.
As per the financials filed for FY 2025, the company reported a revenue of ₹12,000. For the same year it recorded a net profit of ₹4,749 (net margin 39.6%) and EBITDA of ₹4,749 (EBITDA margin 39.6%).
Company details
Contact details
Hekakare Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressUgf29/500/20/A/2, Gali No 2, New Delhi, Delhi, India – 110032
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Hekakare Pharmaceuticals Private Limited
FY 2025 filings availableHekakare Pharmaceuticals Private Limited reported revenue of ₹12,000 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹4,749 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹4,749 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 39.6% | ||
| Net Profit Margin | 39.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Hekakare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hekakare Pharmaceuticals Private Limited
Hekakare Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Srivastava | Director | 24 Feb 2023 | 3 Years 8 Months | Current |
| Hridesh Kumar | Director | 24 Feb 2023 | 3 Years 8 Months | Current |
Peer comparison
Hekakare Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Giva Pharmaceuticals Private Limited | ₹12,120 (FY 2020) | Sultanpur, Uttar Pradesh, India | ||||
| Zeeknil Pharmaceuticals Private Limited | ₹12,082 (FY 2025) | -88.0% | Jaipur, Rajasthan, India | |||
| Hekakare Pharmaceuticals Private Limitedthis company | ₹12,000 (FY 2025) | ₹4,749 | 39.6% | New Delhi, Delhi, India | ||
| Andyeo Pharmaceuticals P Ltd | ₹12,000 (FY 2016) | Haryana, India | ||||
| Inomed Pharmaceuticals Private Limited | ₹12,000 (FY 2025) | Delhi, India | ||||
| Ishir Pharmaceuticals Private Limited | ₹12,000 (FY 2023) | 76.0% | New Delhi, Delhi, India | |||
| Ramgyan Pharmaceuticals Private Limited | ₹11,500 (FY 2024) | Delhi, India | ||||
| Life Stance Pharmaceuticals Private Limited | ₹11,245 (FY 2025) | Pune, Maharashtra, India | ||||
| Suchi Pharmaceuticals Private Limited | ₹10,800 (FY 2022) | Noida, Uttar Pradesh, India | ||||
| Shri Hari Drugs and Pharmaceuticals Private Limited | ₹10,500 (FY 2022) | -21.0% | Mumbai, Maharashtra, India | |||
| Tia Pharmaceuticals Private Limited | ₹10,040 (FY 2025) | -65.0% | Naraingarh, Haryana, India |
To see the full peer comparison of Hekakare Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hekakare Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hekakare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hekakare Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hekakare Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Arvind Kumar Srivastava was appointed as Director on 24 Feb 2023.
Frequently asked questions
Hekakare Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 24 February 2023 (3+ years old) and is registered under CIN U46497DL2023PTC410575.
Hekakare Pharmaceuticals has 2 current directors:
- Arvind Kumar Srivastava - Director
- Hridesh Kumar - Director
The latest financial statements of Hekakare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Hekakare Pharmaceuticals is U46497DL2023PTC410575. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hekakare Pharmaceuticals was incorporated on 24 February 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Hekakare Pharmaceuticals by revenue are Giva Pharmaceuticals Private Limited, Zeeknil Pharmaceuticals Private Limited, Andyeo Pharmaceuticals P Ltd, Inomed Pharmaceuticals Private Limited, Ishir Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Arvind Kumar Srivastava was appointed as Director on 24 Feb 2023. Hridesh Kumar was appointed as Director on 24 Feb 2023.
The registered office of Hekakare Pharmaceuticals is at Ugf2950020A2, Gali No 2, New Delhi, Delhi, India – 110032.
Hekakare Pharmaceuticals can be reached at its registered office: Ugf2950020A2, Gali No 2, New Delhi, Delhi, India – 110032.
Hekakare Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
